FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891363625> ?p ?o ?g. }

• W2891363625 abstract "Chondrosarcomas are malignant cartilage tumors showing relative resistance to conventional chemo- and radiotherapy. Previous studies showed that chondrosarcoma cells could be sensitized to chemotherapy by inhibiting the Bcl-2 family members Bcl-2, Bcl-xl and Bcl-w using ABT-737. In this study we explored the specific role of Bcl-2 family members to identify the most important player in chondrosarcoma cell survival and chemo resistance. Immunohistochemistry was performed on tissue microarrays containing 137 conventional chondrosarcomas of different grades. Selective inhibition of Bcl-2 (S55746) or Bcl-xl (WEHI-539 or A-1155463) and the combination with doxorubicin or cisplatin was investigated in a panel of 8 chondrosarcoma cell lines using presto blue viability assays and caspase 3/7 glo apoptosis assays. In addition Bcl-2 and Bcl-xl inhibition was investigated in an orthotopic Swarm Rat Chondrosarcoma (SRC) model. Bcl-2 and Bcl-xl were most abundantly expressed in the primary tumors, and expression increased with increasing histological grade. A subset of chondrosarcoma cell lines was sensitive to selective inhibition of Bcl-xl, and synergy was observed with doxorubicin or cisplatin in 3 out of 8 chondrosarcoma cell lines resulting in apoptosis. Conversely, selective inhibition of Bcl-2 was not effective in chondrosarcoma cell lines and could not sensitize to chemotherapy. In vivo, selective inhibition of Bcl-xl, but not Bcl-2 resulted in a decrease in tumor growth rate, even though no sensitization to doxorubicin was observed. These results suggest that among the Bcl-2 family members, Bcl-xl is most important for chondrosarcoma survival. Further research is needed to validate whether single or combination treatment with chemotherapy will be beneficial for chondrosarcoma patients." @default.
• W2891363625 created "2018-09-27" @default.
• W2891363625 creator A5026754558 @default.
• W2891363625 creator A5031090394 @default.
• W2891363625 creator A5033452000 @default.
• W2891363625 creator A5055786979 @default.
• W2891363625 creator A5066142399 @default.
• W2891363625 creator A5073493197 @default.
• W2891363625 creator A5075383339 @default.
• W2891363625 creator A5076690638 @default.
• W2891363625 creator A5083401778 @default.
• W2891363625 date "2018-09-21" @default.
• W2891363625 modified "2023-10-16" @default.
• W2891363625 title "Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma" @default.
• W2891363625 cites W1869180184 @default.
• W2891363625 cites W1991108941 @default.
• W2891363625 cites W1991213319 @default.
• W2891363625 cites W2005165035 @default.
• W2891363625 cites W2009271207 @default.
• W2891363625 cites W2013768145 @default.
• W2891363625 cites W2037760271 @default.
• W2891363625 cites W2037968844 @default.
• W2891363625 cites W2059306153 @default.
• W2891363625 cites W2066404900 @default.
• W2891363625 cites W2066640259 @default.
• W2891363625 cites W2071426227 @default.
• W2891363625 cites W2072814179 @default.
• W2891363625 cites W2073239885 @default.
• W2891363625 cites W2076692938 @default.
• W2891363625 cites W2085419794 @default.
• W2891363625 cites W2086612689 @default.
• W2891363625 cites W2097509670 @default.
• W2891363625 cites W2110525250 @default.
• W2891363625 cites W2112992566 @default.
• W2891363625 cites W2115147179 @default.
• W2891363625 cites W2125221126 @default.
• W2891363625 cites W2150312029 @default.
• W2891363625 cites W2154193486 @default.
• W2891363625 cites W2164786703 @default.
• W2891363625 cites W2168546413 @default.
• W2891363625 cites W2170878678 @default.
• W2891363625 cites W2223501982 @default.
• W2891363625 cites W2291176625 @default.
• W2891363625 cites W2519170380 @default.
• W2891363625 cites W2589060305 @default.
• W2891363625 cites W2611221742 @default.
• W2891363625 cites W2765825833 @default.
• W2891363625 cites W2793766280 @default.
• W2891363625 cites W4232199544 @default.
• W2891363625 doi "https://doi.org/10.1038/s41389-018-0084-0" @default.
• W2891363625 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6155044" @default.
• W2891363625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30242253" @default.
• W2891363625 hasPublicationYear "2018" @default.
• W2891363625 type Work @default.
• W2891363625 sameAs 2891363625 @default.
• W2891363625 citedByCount "38" @default.
• W2891363625 countsByYear W28913636252019 @default.
• W2891363625 countsByYear W28913636252020 @default.
• W2891363625 countsByYear W28913636252021 @default.
• W2891363625 countsByYear W28913636252022 @default.
• W2891363625 countsByYear W28913636252023 @default.
• W2891363625 crossrefType "journal-article" @default.
• W2891363625 hasAuthorship W2891363625A5026754558 @default.
• W2891363625 hasAuthorship W2891363625A5031090394 @default.
• W2891363625 hasAuthorship W2891363625A5033452000 @default.
• W2891363625 hasAuthorship W2891363625A5055786979 @default.
• W2891363625 hasAuthorship W2891363625A5066142399 @default.
• W2891363625 hasAuthorship W2891363625A5073493197 @default.
• W2891363625 hasAuthorship W2891363625A5075383339 @default.
• W2891363625 hasAuthorship W2891363625A5076690638 @default.
• W2891363625 hasAuthorship W2891363625A5083401778 @default.
• W2891363625 hasBestOaLocation W28913636251 @default.
• W2891363625 hasConcept C126322002 @default.
• W2891363625 hasConcept C142724271 @default.
• W2891363625 hasConcept C149150037 @default.
• W2891363625 hasConcept C185592680 @default.
• W2891363625 hasConcept C190283241 @default.
• W2891363625 hasConcept C204232928 @default.
• W2891363625 hasConcept C2776302905 @default.
• W2891363625 hasConcept C2776694085 @default.
• W2891363625 hasConcept C2776789625 @default.
• W2891363625 hasConcept C2778239845 @default.
• W2891363625 hasConcept C2781303535 @default.
• W2891363625 hasConcept C31573885 @default.
• W2891363625 hasConcept C502942594 @default.
• W2891363625 hasConcept C54355233 @default.
• W2891363625 hasConcept C55493867 @default.
• W2891363625 hasConcept C71924100 @default.
• W2891363625 hasConcept C81885089 @default.
• W2891363625 hasConcept C86803240 @default.
• W2891363625 hasConceptScore W2891363625C126322002 @default.
• W2891363625 hasConceptScore W2891363625C142724271 @default.
• W2891363625 hasConceptScore W2891363625C149150037 @default.
• W2891363625 hasConceptScore W2891363625C185592680 @default.
• W2891363625 hasConceptScore W2891363625C190283241 @default.
• W2891363625 hasConceptScore W2891363625C204232928 @default.
• W2891363625 hasConceptScore W2891363625C2776302905 @default.
• W2891363625 hasConceptScore W2891363625C2776694085 @default.
• W2891363625 hasConceptScore W2891363625C2776789625 @default.
• W2891363625 hasConceptScore W2891363625C2778239845 @default.

• next